1,145.00p+55.00 (+5.05%)09 May 2024, 16:01
Jump to:
4Basebio PLC Fundamentals
Company Name | 4Basebio PLC | Last Updated | 2024-05-09 |
---|---|---|---|
Industry | Biotechnology | Sector | Healthcare |
Shares in Issue | 12.805 m | Market Cap | £146.62 m |
PE Ratio | 0.00 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | -£0.42 | EPS Growth (%) | 0 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0 | Debt Equity Ratio | 0 |
Asset Equity Ratio | 3.3879 | Cash Equity Ratio | 1.0431 |
Quick Ratio | 2.4380 | Current Ratio | 3.42 |
Price To Book Value | 40.9836 | ROCE | 0 |
4Basebio PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
4Basebio PLC Company Financials
Assets | 2022 | 2021 |
---|---|---|
Tangible Assets | £3.63 m | £2.76 m |
Intangible Assets | £2.12 m | £1.27 m |
Investments | 0 | 0 |
Total Fixed Assets | £5.79 m | £4.06 m |
Stocks | £133,000.00 | £156,000.00 |
Debtors | £54,000.00 | £46,000.00 |
Cash & Equivalents | £4.35 m | £9.59 m |
Other Assets | 0 | 0 |
Total Assets | £11.69 m | £14.70 m |
Liabilities | 2022 | 2021 |
---|---|---|
Creditors within 1 year | £1.52 m | £1.52 m |
Creditors after 1 year | £3.05 m | £1.48 m |
Other Liabilities | 0 | 0 |
Total Liabilities | £4.57 m | £3.01 m |
Net assets | £7.12 m | £11.70 m |
Equity | 2022 | 2021 |
---|---|---|
Called up share capital | £11.13 m | £11.13 m |
Share Premium | £706,000.00 | £706,000.00 |
Profit / Loss | -£5.93 m | -£3.64 m |
Other Equity | £7.12 m | £11.70 m |
Preference & Minorities | 0 | 0 |
Total Capital Employed | £7.12 m | £11.70 m |
Ratios | 2022 | 2021 |
---|---|---|
Debt Ratio | £0.29 | £0.10 |
Debt-to-Equity | £0.41 | £0.11 |
Assets / Equity | 3.3879 | 3.3879 |
Cash / Equity | 1.0431 | 1.0431 |
EPS | -£0.42 | -£0.24 |
Cash Flow | 2022 | 2021 |
---|---|---|
Cash from operating activities | -£4.70 m | -£2.74 m |
Cashflow before financing | -£3.46 m | -£3.21 m |
Increase in Cash | -£5.40 m | -£4.72 m |
Income | 2022 | 2021 |
---|---|---|
Turnover | £268,000.00 | £338,000.00 |
Cost of sales | £29,000.00 | £69,000.00 |
Gross Profit | £239,000.00 | £269,000.00 |
Operating Profit | -£5.84 m | -£3.53 m |
Pre-Tax profit | -£5.93 m | -£3.64 m |
4Basebio PLC Company Background
Sector | Healthcare |
---|---|
Activities | 4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use. |
Latest Interim Date | 21 Sep 2023 |
Latest Fiscal Year End Date | 10 May 2024 |
4Basebio PLC Directors
Appointed | Name | Position |
---|---|---|
2021-02-12 | Mr. Timothy Paul McCarthy | Non-Executive Director,Chairman |
2022-05-12 | Dr. Joseph M. Fernandez | Non-Executive Director |
2021-02-12 | Mr. Hansjorg Plaggemars | Non-Executive Director |
2024-02-05 | Dr. Heikki Lanckriet, PhD | Executive Director,Chief Executive Officer |
2024-02-05 | Mr. David John Roth | Executive Director,Chief Financial Officer and Company Secretary |
4Basebio PLC Contact Details
Company Name | 4basebio PLC |
---|---|
Address | 25 Norman Way, Over, Cambridge, CB24 5QE |
Telephone | +44 1223967943 |
Website | https://www.4basebio.com |
4Basebio PLC Advisors
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Harbour Energy PLC | 301.10 | 7.69 |
Hays PLC | 97.90 | 4.09 |
Watches Of Switzerland Group PLC | 336.80 | 3.63 |
Pz Cussons PLC | 105.60 | 3.33 |
Marshalls PLC | 292.50 | 3.17 |
Genuit Group PLC | 455.50 | 3.17 |
Fallers
Company | Price | % Chg |
---|---|---|
Patria Private Equity Trust PLC | 534.00 | -5.49 |
3I Group PLC | 2,820.00 | -5.18 |
Petershill Partners PLC | 200.00 | -4.76 |
Baltic Classifieds Group PLC | 236.50 | -4.25 |
HSBC Holdings PLC | 690.90 | -4.15 |
Bellevue Healthcare Trust PLC | 141.60 | -3.41 |